Keyword search

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Cardiovascular health measures of the household population, by sex and age group.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the skin and subcutaneous tissue, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the musculoskeletal system and connective tissue, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the genitourinary system, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by certain conditions originating in the perinatal period, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the ear and mastoid process, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the respiratory system, by age group and sex, 2000 to most recent year.

Description: Anthropometry measures of the household population, by sex and age group.

Description:

Number and percentage of Canadians aged 5 to 79 with a measured body mass index categorized as overweight or obese, by age group and sex.

Description: Average blood pressure (systolic and diastolic) and heart rate measurements of the household population, by age group and sex. Blood pressure and heart rate were measured using the OMRON blood pressure monitor.

Description:

Since the early 1980s, the overall hospitalization rate in Canada has fallen sharply, but the rate for inflammatory bowel disease (IBD) has been stable. To some degree, this stability during an era of decline reflects the high rate of readmission among IBD patients, with more than 20% having at least two hospital stays during the course of a year.

Description:

- Between 1979 and 2001, 599 deaths in Canada were attributed to Creutzfeldt-Jakob disease (CJD), only one of which was related to bovine spongiform encephalopathy (BSE), known as "mad cow disease."

- CJD mortality rates rise with age and are highest among people in their seventies.

Description:

This article examines which groups have high rates of injury and what activities are most likely to produce injuries.

Description:

Five-year relative survival ratios for prostate and breast cancer rose substantially in the 1985 to 1987 and the 1992 to 1994 periods. Increases in survival ratios for colorectal cancer over the same periods were smaller, but still statistically significant. Relative survival for lung cancer changed little.

Description:

In 2000/01, 28% of Canadians aged 20 or older reported having had a flu shot in the previous year, up from 16% in 1996/97. Close to two-thirds of seniors and one-half of people with chronic conditions had been vaccinated. Among the minority of seniors who did not get a flu shot, the main reason for not getting a shot was that they thought it was unnecessary.

Description:

In 2000/01, 19% of men and 31% of women aged 40 or older reported having been diagnosed with arthritis. Independent of other factors such as age, household income, daily lifting, physician visits and psychological distress, the odds of developing arthritis were higher for both sexes among those who were obese, compared with individuals of acceptable weight.

Description:

This article investigates behaviours, circumstances and parental characteristics that relate to obesity in adolescents. Differences between boys and girls, which may reflect gender-specific social pressures and responses to such pressures, are also explored.

Description:

The Classification and Measurement System for Functional Health (CLAMES) is a generic tool developed by the Health Analysis and Measurement Group of Statistics Canada to quantify the health-related quality of life associated with diseases and injuries.

This comprehensive tool permits comparable description and classification of health states covering a broad range of severity levels and symptoms. It can be used to compare the impact of disease or injury in a population, to monitor population health over time, and to identify disparities among socio-demographic groups.

Like existing generic tools such as the Health Utilities Index (HUI 3), the EuroQol five dimensions index (EQ-5D) and the SF-36 Health Status Questionnaire, CLAMES measures health status and health-related quality of life. CLAMES combines the attributes used in these tools so that we can characterize diseases and injuries across all aspects of health - physical, mental, and social.

Description:

In 2000/01, 10% of Canadians aged 20 or older, an estimated 2.3 million, reported having had a repetitive strain injury (RSI) in the past 12 months. Work-related activities were most often the cause. People with RSIs had more contact with health care professionals and higher levels of chronic pain and psychological distress than did those without an RSI.

Description:

The impact of chronic conditions on health status varies at different ages. At younger ages, urinary incontinence and arthritis/rheumatism significantly compromise health-related quality of life, while at older ages, Alzheimer's disease and stroke have the greatest effect.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

Description:

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

Description:

This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.